Article
Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism.
Blood pressure - 1 Aug 2018
Maiolino Giuseppe, Ceolotto Giulio, Battistel Michele, Barbiero Giulio, Cesari Maurizio, Amar Laurence, Caroccia Brasilina, Padrini Roberto, Azizi Michel, Rossi Gian Paolo
Abstract excerpt
PURPOSE: Aldosterone-producing adenoma (APA) is the main curable cause of endocrine hypertension cause of primary aldosteronism (PA) and it is in up to 66% of all cases investigated with adrenal vein sampling (AVS). Mutations in the KCNJ5 potassium channel involve up to 70% of APA and cause the most florid PA phenotypes. The recent finding that macrolide antibiotics specifically inhibit in vitro the altered...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
